Depression in advanced disease: a systematic review. Part 1: Prevalence and case finding

Hotopf, M; Chidgey, J; Addington-Hall, J; Lan Ly, K
March 2002
Palliative Medicine;Mar2002, Vol. 16 Issue 2, p81
Academic Journal
Objective: To identify all literature regarding depression in patients with advanced cancer and among mixed hospice populations, and to summarise the prevalence of depression according to different definitions. Methods: A systematic review was performed using extensive electronic and hand searches. All studies with quantitative data on prevalence of depression were included and categorised according to their definition of depression. Results: We identified 46 eligible studies giving information on the prevalence of depression, and a further four which gave information on case finding. The most widely used assessment of depression was the Hospital Anxiety and Depression Scale (HADS), which gave a median prevalence of 'definite depression' (i.e., a score on the depression subscale of >10) of 29%, (interquartile range, IQR, 19.50-34.25%). Studies that used psychiatric interviews indicated a prevalence of major depressive disorder ranging from 5% to 26%, with a median of 15%. Studies were generally small (median sample size 88.5, IQR 50-108), had high numbers of nonresponders, and rarely gave confidence intervals for estimates of prevalence. Conclusions: Depression is a common problem in palliative care settings. The quality of much of the available research is poor, based on small samples of patients with very high nonparticipation rates. The clinical importance of depression is described in subsequent papers.


Related Articles

  • The treatment of depression in cancer patients: a systematic review. Gary Rodin; Nancy Lloyd; Mark Katz; Esther Green; Jean Mackay; Rebecca Wong // Supportive Care in Cancer;Feb2007, Vol. 15 Issue 2, p123 

    AbstractGoals of the work:??To evaluate the efficacy of pharmacological and nonpharmacological treatments for depression in cancer populations.Materials and methods:??The Supportive Care Guidelines Group conducted a systematic review of the published literature through June 2005. Search sources...

  • The prevalence of anxiety and depression in palliative care patients with cancer in Western Australia and New South Wales. O'Connor, Moira; White, Kate; Kristjanson, Linda J.; Cousins, Kerry; Wilkes, Lesley // Medical Journal of Australia;9/6/2010 Supplement, Vol. 193, p544 

    The article presents a study which examined the prevalence and factors of anxiety and depression among cancer patients in palliative care settings in Western Australia (WA) and New South Wales (NSW). The researchers utilized the Hospital Anxiety and Depression Scale (HADS), demographic...

  • Noncancer life stresses in newly diagnosed cancer. Markku Ojanen; Anna Väkevä; Arpo Aromaa // Supportive Care in Cancer;Nov2008, Vol. 16 Issue 11, p1231 

    Abstract Goals of work  Noncancer life stresses affect psychosocial stress processes and have an impact on quality of life (QOL) of the patients. However, investigating life stresses in cancer is a recent development. We evaluated the life stresses of newly diagnosed melanoma, breast...

  • Depression--the hidden symptom in advanced cancer. Lloyd-Williams, Mari // Journal of the Royal Society of Medicine;Dec2003, Vol. 96 Issue 12, p577 

    The article discusses the role of screening tools on the treatment of depression, which is said to be a symptom in advanced cancer. Because patients are not eager to describe their depressive symptoms, staff need to know how to recognize depression. One method of assessing depression is through...

  • Depression, quality of life and breast cancer: a review of the literature. M. Reich; A. Lesur; C. Perdrizet-Chevallier // Breast Cancer Research & Treatment;Jul2008, Vol. 110 Issue 1, p9 

    Abstract  Depression is misdiagnosed and undertreated among breast cancer population. Risk factors for depression in the 5 years after diagnosis are related more to the patient rather than to the disease or its treatment. The breast cancer stage (early and advanced) is not statistically...

  • Putting Evidence Into Practice®: Interventions for Depression. Fulcher, Carul D.; Badger, Terry; Gunter, Ashley K.; Marrs, Joyce; Reese, Jill M. // Clinical Journal of Oncology Nursing;Feb2008, Vol. 12 Issue 1, p131 

    Depression and depressive symptoms are prevalent in people with cancer, yet interventions for depression are a low priority for most oncology care providers. Barriers to diagnosis and treatment include beliefs by patients and providers that depression is an expected correlate of cancer...

  • How Do We Interpret the Answer "Neither" When Physicians Ask Patients with Cancer "Are You Depressed or Not?". Ohno, Tatsuya; Noguchi, Wataru; Nakayama, Yuko; Kato, Shingo; Tsujii, Hirohiko; Suzuki, Yoshihiko // Journal of Palliative Medicine;Aug2006, Vol. 9 Issue 4, p861 

    Objectives: The aim of this study was to clarify how physicians should interpret the answer "neither" to the single-question interview, "Are you depressed or not?" Patients and methods: Two hundred fifty-one patients with cancer were studied. The patients were directly interviewed, choosing one...

  • Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: a pilot study. Amodeo, Laura; Castelli, Lorys; Leombruni, Paolo; Cipriani, Daniela; Biancofiore, Alessia; Torta, Riccardo // Supportive Care in Cancer;Feb2012, Vol. 20 Issue 2, p375 

    Objectives: This study aimed to compare the tolerability and efficacy of two different titrations of paroxetine (slow and standard) in a population of cancer patients with depression. Methods: This randomized open trial included 30 cancer patients with depression (major depressive disorder,...

  • The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients. Warmenhoven, Franca; Rijswijk, Eric; Engels, Yvonne; Kan, Cornelis; Prins, Judith; Weel, Chris; Vissers, Kris // Supportive Care in Cancer;Feb2012, Vol. 20 Issue 2, p319 

    Purpose: Depression is highly prevalent in advanced cancer patients, but the diagnosis of depressive disorder in patients with advanced cancer is difficult. Screening instruments could facilitate diagnosing depressive disorder in patients with advanced cancer. The aim of this study was to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics